Seagen - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Seagen M&A Summary

Seagen has acquired 1 company of its own.

Seagen’s largest acquisition to date was in 2018, when it acquired Cascadian Therapeutics for $614M. Seagen has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Seagen Ownership

Who owns Seagen?

Seagen is owned by Pfizer. It was acquired on March 13, 2023.

Seagen Business Overview

Where is Seagen headquartered?

Seagen is headquartered in Bothell, Washington.

What is Seagen’s revenue?

Seagen disclosed revenue of 1,962M USD for 2022 and 1,574M USD for 2021.

What sector is Seagen in?

Seagen is a life science company.

When was Seagen founded?

Seagen was founded in 1997.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 4


Seagen, Inc.

21823 30th Drive SE,
Bothell, Washington 98021
United States,
(425) 527-4000

Seagen is a biotechnology company provides an antibody-drug conjugate (ADC) technology harnesses the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells. Seattle Genetics commercializes ADCETRIS (brentuximab vedotin) for the treatment of several types of CD30-expressing lymphomas. Seattle was founded in 1997 and is based in Bothell, Washington.

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $614M $614M
Sell (0.0/yr) # - - - - - - 0

Most Recent M&A

Company Date Value Type
Cascadian Therapeutics, Inc. 2018-01-31 614M USD Add-on Acquisition
Seattle, Washington ·
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 614M (100%) - -
Total 1 $614M - -

By Geo

State/Country Buy Value Sell Value
United States 1 614M - -
  Washington 1 614M - -
Total 1 $614M - -

Top M&A Advisors

Financial Deals
Leerink Partners LLC
J.P. Morgan Securities
Barclays Investment Bank
Legal Deals
Sullivan & Cromwell

Deal Values

buy # Total
$100M to $1B 1 $614M
Largest Cascadian Therapeutics, Inc.
$614M (2018-01-31)

 Subscribe to unlock this and 203,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 195K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 76K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.